Not Yet RecruitingNot Applicable

The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients

Taiwan100 participantsStarted 2026-01-19

Plain-language summary

This study will elucidate the role of 3D transvaginal ultrasound in assessing (1) cervical vascularity and blood flow in patients with cervical cancer and cervical intraepithelial neoplasm, and (2) tumor vascularity and blood flow in patients with ovarian cancer.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult women who have had a normal cervical smear within the past three years and have no other gynecological cancers (control group).
✓. Adult women with cervical cancer or precancerous lesions.
✓. Adult women suspected of having ovarian cancer, fallopian tube cancer, or peritoneal cancer before surgery.

Exclusion criteria

✕. Patients who cannot cooperate with vaginal or abdominal 3D ultrasound scans.

What they're measuring

Vascularization-flow index

Timeframe: 3 years

Trial details

NCT IDNCT07385976

SponsorFar Eastern Memorial Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12-31

View on ClinicalTrials.gov More Cervical Cancer trials